{
    "nctId": "NCT03733106",
    "briefTitle": "Prospective Trial of Digital Breast Tomosynthesis (DBT) in Breast Cancer Screening.",
    "officialTitle": "Prospective Randomized Trial of Digital Breast Tomosynthesis (DBT) Plus Standard 2D Digital Mammography (2DDM) or Synthetic 2D Digital Mammography (S2D) Compared to Standard 2DDM in Breast Cancer Screening.",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 100000,
    "primaryOutcomeMeasure": "To compare the cost effectiveness of breast cancer screening with digital breast tomosynthesis and 2DDM vs standard screening with 2DDM",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* women aged 50-70 years attending for routine breast cancer screening\n\nExclusion Criteria:\n\n* women aged 47-49 and 71-73 invited to participate in the age extension trial\n* women who are unable to give informed consent",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}